The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Milk Oligosaccharides (HMO) Market Outlook 2024
Synopsis
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Global Human Milk Oligosaccharides (HMO) key players include Abbott, Inbiose, Elicityl SA, Jennewein Biotechnologie, ZuChem, etc. North America is the largest consumption market, with a share about 65%, followed by Europe, with a share about 30 percent. In terms of product, 2'-FL & 3-FL is the largest segment, with a share about 70%. And in terms of application, the largest application is Infant Formula, followed by Functional Food & Beverages, and Food/Medical Supplements.
The global Human Milk Oligosaccharides (HMO) market was valued at US$ 385 million in 2020 and is expected to reach US$ 2535.6 million by the end of 2027, growing at a CAGR of 30.6% during 2021-2027.
This report focuses on Human Milk Oligosaccharides (HMO) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Human Milk Oligosaccharides (HMO) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Human Milk Oligosaccharides (HMO) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Segment by Application
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott
Inbiose
Elicityl SA
Jennewein Biotechnologie
ZuChem
Dextra Laboratories
Glycom
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Global Human Milk Oligosaccharides (HMO) key players include Abbott, Inbiose, Elicityl SA, Jennewein Biotechnologie, ZuChem, etc. North America is the largest consumption market, with a share about 65%, followed by Europe, with a share about 30 percent. In terms of product, 2'-FL & 3-FL is the largest segment, with a share about 70%. And in terms of application, the largest application is Infant Formula, followed by Functional Food & Beverages, and Food/Medical Supplements.
The global Human Milk Oligosaccharides (HMO) market was valued at US$ 385 million in 2020 and is expected to reach US$ 2535.6 million by the end of 2027, growing at a CAGR of 30.6% during 2021-2027.
This report focuses on Human Milk Oligosaccharides (HMO) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Human Milk Oligosaccharides (HMO) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Human Milk Oligosaccharides (HMO) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Segment by Application
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott
Inbiose
Elicityl SA
Jennewein Biotechnologie
ZuChem
Dextra Laboratories
Glycom
Index1 Human Milk Oligosaccharides (HMO) Market Overview
1.1 Product Overview and Scope of Human Milk Oligosaccharides (HMO)
1.2 Human Milk Oligosaccharides (HMO) Segment by Type
1.2.1 Global Human Milk Oligosaccharides (HMO) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 2'-FL & 3-FL
1.2.3 Sialyllactose
1.2.4 LNT & LNnT
1.3 Human Milk Oligosaccharides (HMO) Segment by Application
1.3.1 Global Human Milk Oligosaccharides (HMO) Sales Comparison by Application: (2021-2027)
1.3.2 Infant Formula
1.3.3 Functional Food & Beverages
1.3.4 Food/Medical Supplements
1.3.5 Other
1.4 Global Human Milk Oligosaccharides (HMO) Market Size Estimates and Forecasts
1.4.1 Global Human Milk Oligosaccharides (HMO) Revenue 2016-2027
1.4.2 Global Human Milk Oligosaccharides (HMO) Sales 2016-2027
1.4.3 Human Milk Oligosaccharides (HMO) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Human Milk Oligosaccharides (HMO) Market Competition by Manufacturers
2.1 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Milk Oligosaccharides (HMO) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Milk Oligosaccharides (HMO) Manufacturing Sites, Area Served, Product Type
2.5 Human Milk Oligosaccharides (HMO) Market Competitive Situation and Trends
2.5.1 Human Milk Oligosaccharides (HMO) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Milk Oligosaccharides (HMO) Players Market Share by Revenue
2.5.3 Global Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Milk Oligosaccharides (HMO) Retrospective Market Scenario by Region
3.1 Global Human Milk Oligosaccharides (HMO) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Human Milk Oligosaccharides (HMO) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.3.1 North America Human Milk Oligosaccharides (HMO) Sales by Country
3.3.2 North America Human Milk Oligosaccharides (HMO) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.4.1 Europe Human Milk Oligosaccharides (HMO) Sales by Country
3.4.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Milk Oligosaccharides (HMO) Market Facts & Figures by Region
3.5.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Region
3.5.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.6.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Country
3.6.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country
3.7.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Human Milk Oligosaccharides (HMO) Historic Market Analysis by Type
4.1 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2016-2021)
4.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2016-2021)
4.3 Global Human Milk Oligosaccharides (HMO) Price by Type (2016-2021)
5 Global Human Milk Oligosaccharides (HMO) Historic Market Analysis by Application
5.1 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2016-2021)
5.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2016-2021)
5.3 Global Human Milk Oligosaccharides (HMO) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Inbiose
6.2.1 Inbiose Corporation Information
6.2.2 Inbiose Description and Business Overview
6.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Portfolio
6.2.5 Inbiose Recent Developments/Updates
6.3 Elicityl SA
6.3.1 Elicityl SA Corporation Information
6.3.2 Elicityl SA Description and Business Overview
6.3.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Portfolio
6.3.5 Elicityl SA Recent Developments/Updates
6.4 Jennewein Biotechnologie
6.4.1 Jennewein Biotechnologie Corporation Information
6.4.2 Jennewein Biotechnologie Description and Business Overview
6.4.3 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Product Portfolio
6.4.5 Jennewein Biotechnologie Recent Developments/Updates
6.5 ZuChem
6.5.1 ZuChem Corporation Information
6.5.2 ZuChem Description and Business Overview
6.5.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 ZuChem Human Milk Oligosaccharides (HMO) Product Portfolio
6.5.5 ZuChem Recent Developments/Updates
6.6 Dextra Laboratories
6.6.1 Dextra Laboratories Corporation Information
6.6.2 Dextra Laboratories Description and Business Overview
6.6.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Portfolio
6.6.5 Dextra Laboratories Recent Developments/Updates
6.7 Glycom
6.6.1 Glycom Corporation Information
6.6.2 Glycom Description and Business Overview
6.6.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Glycom Human Milk Oligosaccharides (HMO) Product Portfolio
6.7.5 Glycom Recent Developments/Updates
7 Human Milk Oligosaccharides (HMO) Manufacturing Cost Analysis
7.1 Human Milk Oligosaccharides (HMO) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)
7.4 Human Milk Oligosaccharides (HMO) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Milk Oligosaccharides (HMO) Distributors List
8.3 Human Milk Oligosaccharides (HMO) Customers
9 Human Milk Oligosaccharides (HMO) Market Dynamics
9.1 Human Milk Oligosaccharides (HMO) Industry Trends
9.2 Human Milk Oligosaccharides (HMO) Growth Drivers
9.3 Human Milk Oligosaccharides (HMO) Market Challenges
9.4 Human Milk Oligosaccharides (HMO) Market Restraints
10 Global Market Forecast
10.1 Human Milk Oligosaccharides (HMO) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Milk Oligosaccharides (HMO) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Human Milk Oligosaccharides (HMO) by Type (2022-2027)
10.2 Human Milk Oligosaccharides (HMO) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Milk Oligosaccharides (HMO) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Human Milk Oligosaccharides (HMO) by Application (2022-2027)
10.3 Human Milk Oligosaccharides (HMO) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Milk Oligosaccharides (HMO) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Human Milk Oligosaccharides (HMO) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Human Milk Oligosaccharides (HMO) Sales (Kg) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Human Milk Oligosaccharides (HMO) Sales (Kg) Comparison by Application (2021-2027)
Table 3. Global Human Milk Oligosaccharides (HMO) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Human Milk Oligosaccharides (HMO) Covered in This Study
Table 5. Global Human Milk Oligosaccharides (HMO) Sales (Kg) of Key Manufacturers (2016-2021)
Table 6. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Human Milk Oligosaccharides (HMO) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Human Milk Oligosaccharides (HMO) Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Human Milk Oligosaccharides (HMO) Manufacturing Sites and Area Served
Table 11. Manufacturers Human Milk Oligosaccharides (HMO) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human Milk Oligosaccharides (HMO) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Milk Oligosaccharides (HMO) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Human Milk Oligosaccharides (HMO) Sales by Region (2016-2021) & (Kg)
Table 16. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2016-2021)
Table 17. Global Human Milk Oligosaccharides (HMO) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Human Milk Oligosaccharides (HMO) Sales by Country (2016-2021) & (Kg)
Table 19. North America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2016-2021)
Table 20. North America Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2016-2021)
Table 22. Europe Human Milk Oligosaccharides (HMO) Sales by Country (2016-2021) & (Kg)
Table 23. Europe Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2016-2021)
Table 24. Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2016-2021) & (Kg)
Table 27. Asia Pacific Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2016-2021) & (Kg)
Table 31. Latin America Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2016-2021)
Table 32. Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2016-2021) & (Kg)
Table 35. Middle East and Africa Human Milk Oligosaccharides (HMO) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue Market Share by Country (2016-2021)
Table 38. Global Human Milk Oligosaccharides (HMO) Sales (Kg) by Type (2016-2021)
Table 39. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2016-2021)
Table 40. Global Human Milk Oligosaccharides (HMO) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Human Milk Oligosaccharides (HMO) Revenue Share by Type (2016-2021)
Table 42. Global Human Milk Oligosaccharides (HMO) Price (USD/Kg) by Type (2016-2021)
Table 43. Global Human Milk Oligosaccharides (HMO) Sales (Kg) by Application (2016-2021)
Table 44. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2016-2021)
Table 45. Global Human Milk Oligosaccharides (HMO) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Human Milk Oligosaccharides (HMO) Revenue Share by Application (2016-2021)
Table 47. Global Human Milk Oligosaccharides (HMO) Price (USD/Kg) by Application (2016-2021)
Table 48. Abbott Corporation Information
Table 49. Abbott Description and Business Overview
Table 50. Abbott Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Abbott Human Milk Oligosaccharides (HMO) Product
Table 52. Abbott Recent Developments/Updates
Table 53. Inbiose Corporation Information
Table 54. Inbiose Description and Business Overview
Table 55. Inbiose Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Inbiose Human Milk Oligosaccharides (HMO) Product
Table 57. Inbiose Recent Developments/Updates
Table 58. Elicityl SA Corporation Information
Table 59. Elicityl SA Description and Business Overview
Table 60. Elicityl SA Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Elicityl SA Human Milk Oligosaccharides (HMO) Product
Table 62. Elicityl SA Recent Developments/Updates
Table 63. Jennewein Biotechnologie Corporation Information
Table 64. Jennewein Biotechnologie Description and Business Overview
Table 65. Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Jennewein Biotechnologie Human Milk Oligosaccharides (HMO) Product
Table 67. Jennewein Biotechnologie Recent Developments/Updates
Table 68. ZuChem Corporation Information
Table 69. ZuChem Description and Business Overview
Table 70. ZuChem Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. ZuChem Human Milk Oligosaccharides (HMO) Product
Table 72. ZuChem Recent Developments/Updates
Table 73. Dextra Laboratories Corporation Information
Table 74. Dextra Laboratories Description and Business Overview
Table 75. Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. Dextra Laboratories Human Milk Oligosaccharides (HMO) Product
Table 77. Dextra Laboratories Recent Developments/Updates
Table 78. Glycom Corporation Information
Table 79. Glycom Description and Business Overview
Table 80. Glycom Human Milk Oligosaccharides (HMO) Sales (Kg), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Glycom Human Milk Oligosaccharides (HMO) Product
Table 82. Glycom Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Human Milk Oligosaccharides (HMO) Distributors List
Table 86. Human Milk Oligosaccharides (HMO) Customers List
Table 87. Human Milk Oligosaccharides (HMO) Market Trends
Table 88. Human Milk Oligosaccharides (HMO) Growth Drivers
Table 89. Human Milk Oligosaccharides (HMO) Market Challenges
Table 90. Human Milk Oligosaccharides (HMO) Market Restraints
Table 91. Global Human Milk Oligosaccharides (HMO) Sales Forecast by Type (2022-2027) & (Kg)
Table 92. Global Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Human Milk Oligosaccharides (HMO) Sales Forecast by Application (2022-2027) & (Kg)
Table 96. Global Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Human Milk Oligosaccharides (HMO) Sales Forecast by Region (2022-2027) & (Kg)
Table 100. Global Human Milk Oligosaccharides (HMO) Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Human Milk Oligosaccharides (HMO) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Human Milk Oligosaccharides (HMO) Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Milk Oligosaccharides (HMO)
Figure 2. Global Human Milk Oligosaccharides (HMO) Market Share by Type in 2020 & 2027
Figure 3. 2'-FL & 3-FL Product Picture
Figure 4. Sialyllactose Product Picture
Figure 5. LNT & LNnT Product Picture
Figure 6. Global Human Milk Oligosaccharides (HMO) Market Share by Application in 2020 & 2027
Figure 7. Infant Formula
Figure 8. Functional Food & Beverages
Figure 9. Food/Medical Supplements
Figure 10. Other
Figure 11. Global Human Milk Oligosaccharides (HMO) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Human Milk Oligosaccharides (HMO) Market Size 2016-2027 (US$ Million)
Figure 13. Global Human Milk Oligosaccharides (HMO) Sales 2016-2027 (Kg)
Figure 14. Global Human Milk Oligosaccharides (HMO) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Human Milk Oligosaccharides (HMO) Sales Share by Manufacturers in 2020
Figure 16. Global Human Milk Oligosaccharides (HMO) Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Human Milk Oligosaccharides (HMO) Players: Market Share by Revenue in 2020
Figure 18. Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region (2016-2021)
Figure 20. Global Human Milk Oligosaccharides (HMO) Sales Market Share by Region in 2020
Figure 21. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region (2016-2021)
Figure 22. Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Region in 2020
Figure 23. U.S. Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Human Milk Oligosaccharides (HMO) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Human Milk Oligosaccharides (HMO) by Type (2016-2021)
Figure 48. Sales Market Share of Human Milk Oligosaccharides (HMO) by Application (2016-2021)
Figure 49. Sales Market Share of Human Milk Oligosaccharides (HMO) by Application in 2020
Figure 50. Revenue Share of Human Milk Oligosaccharides (HMO) by Application (2016-2021)
Figure 51. Revenue Share of Human Milk Oligosaccharides (HMO) by Application in 2020
Figure 52. Manufacturing Cost Structure of Human Milk Oligosaccharides (HMO)
Figure 53. Manufacturing Process Analysis of Human Milk Oligosaccharides (HMO)
Figure 54. Human Milk Oligosaccharides (HMO) Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
